BioXFEL - Resources: GPCR Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for the A<sub>2A</sub> Adenosine Receptor: Citations

Support

Support Options

Knowledge Base

Find information on common issues.
Ask the Community

Ask questions and find answers from other users.
Wish List

Suggest a new site feature or improvement.
Support Tickets

Check on status of your tickets.

Submit a Support Ticket

Username: optional Name: required E-mail: required Please answer the question: required
What day comes after Tuesday? Please leave this field blank. required

Problem: required Attach a screenshot: optional (.jpg, .jpeg, .jpe, .bmp, .tif, .tiff, .png, .gif, .pdf, .zip, .mpg, .mpeg, .avi, .mov, .wmv, .asf, .asx, .ra, .rm, .txt, .rtf, .doc, .xsl, .html, .js, .wav, .mp3, .eps, .ppt, .pps, .swf, .tar, .tex, .gz)

0 Citation(s)

0 questions (Ask a question)

GPCR Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for the A<sub>2A</sub> Adenosine Receptor

By Anna Shiriaeva, Daejin Park, Gyudong Kim, Yoonji Lee, Xiyan Hou, Dnyandev B. Jarhad, Gibae Kim, Jinha Yu, Young Eum Hyun, Woomi Kim, Zhan-Guo Gao, Kenneth A. Jacobson, Gye Won Han, Raymond C. Stevens, Lak Shin Jeong, Sun Choi, Vadim Cherezov¹

1. Bridge Institute - University of Southern California